Life SciencesLiability
SpecialtyStandard / Universal

USP 800 Hazardous Drug Handling

What this clause says

Where Vendor handles drugs designated hazardous by NIOSH, Vendor shall maintain compliance with USP General Chapter <800> covering containment, ventilation, PPE, and waste disposal, with documentation available for Sponsor audit.

What this means in plain English

USP 800 governs handling of hazardous drugs (NIOSH list) — chemotherapy, hormones, antivirals, immunosuppressants. Compliance affects facility design, PPE, environmental controls, and training, with insurance implications for workers comp, products, and pollution.

What it means for a CDMO program

Pharmacies handling hazardous drugs without USP 800 compliance face workers comp surcharges, products liability exclusions, and potential pollution liability gaps. State boards have made USP 800 enforcement a focus since 2022.

How this evaluates

The Decoder applies these rules in order; the first match wins.

  • usp800 › applies is set → Borderline: Hazardous drugs handled — USP 800 documentation must be current.

See this in your MSA

Pre-loaded with this clause selected.

Run the Decoder

Related clauses

Questions about specialty

USP 800 Hazardous Drug Handling — common questions

Which drugs trigger USP 800?

+

The NIOSH hazardous-drug list — most chemotherapy agents, certain hormones, antivirals, and immunosuppressants. NIOSH publishes the list and updates it periodically.

Do I need a separate hazardous-drug compounding room?

+

Yes — USP 800 requires a negative-pressure containment area with proper ventilation, separate from non-hazardous compounding spaces.

What insurance lines does USP 800 affect?

+

Workers comp (occupational hazardous-drug exposure), products liability (cross-contamination claims), and pollution liability (waste-stream and accidental-release exposures).